GammaTile
Device Kxk
General payments
$1,213,106
Research payments
$1,422,796
Through program year 2024, $1,213,106 in general payments and $1,422,796 in research payments were reported against GammaTile (Kxk).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $345,559 | 808 |
| 2024 | Research | $1,414,296 | 233 |
| 2023 | General | $255,754 | 724 |
| 2022 | General | $200,262 | 602 |
| 2021 | General | $254,215 | 290 |
| 2021 | Research | $8,500 | 5 |
| 2020 | General | $156,654 | 64 |
| 2019 | General | $661 | 4 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
2,492 general · 238 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.